News

Bedfont® is recognised for putting people first and scoops the AHM Health & Wellbeing Award. Bedfont® Scientific Limited, an innovative MedTech company that has just celebrated its 49th anniversary, is thrilled to have won the All Health Matters (AHM) Health...

Bedfont® Scientific Limited strengthens community safety with defibrillator donation. Bedfont® Scientific Limited, an innovative MedTech company with over 48 years of experience in breath analysis, has proudly donated a defibrillator to Medway United FC. The club is an integral part...

With the festive holiday season upon us, many tend to indulge in the various rich, festive treats on offer. December is a joyful time; it is also a time to relax and treat yourself; however, the festive eating can take...

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region. Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices,...

Part 3: Asthma treatment in 2024: Navigating the new recommendations for every age After exploring diagnostic changes and the pivotal role of Fractional exhaled Nitric Oxide (FeNO) in asthma care, part 3 of our series shifts the focus to treatment...

Part 2: Why FeNO first? Spotlight on testing & special cases In Part 1, we explored the redefined approach to asthma diagnosis under the new NICE/BTS/SIGN guidelines. In Part 2, we dive deeper into the role of Fractional exhaled Nitric...